gestational diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: (1) All pregnant women conformed to the standard of diagnosis and treatment for GDM6. The diagnosis was confirmed by oral glucose tolerance test (Oral glucose was purchased from Shanghai Yanjin Biotechnology Co., Ltd., No. 9138 Beiqing Road, Qingpu District, Shanghai, China; product number: Js11050-25 g; brand YOYOBIO); (2) The fasting blood glucose (FBG) of pregnant women exceeded 7.0 mmol/L, and the blood glucose exceeded 11.0 mmol/L one hour after taking sugar; (3) The maternal age was over 20 years old; (4) Pregnant women and their families had informed consent and signed the informed consent; (5) Medical records were complete. Participants could cooperate with treatment and could use the Wechat or telephone to finish the post hospital follow-up after discharge.
Exclusion criteria
Exclusion criteria: Exclusion criteria: (1) Pregnant woman who had symptoms of diabetes, such as polydipsia, polydipsia, polyuria or weight loss before pregnancy or these who had made a definite diagnosis as diabetes. (2) Pregnant woman who took antibiotics and other drugs or sugary foods before participating in the study; (3) Pregnant woman who had inflammatory diseases such as inflammatory bowel disease, hypertension and autoimmune diseases. (4) Pregnant woman with severe insufficiency of heart function or liver and kidney function; (5) Pregnant woman was accompanied by mental illness and was unable to cooperate with treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood glucose,FBG;2h postprandial glucose,2hPG; | — |
Countries
China
Contacts
Hunan provincial maternal and child health care hospital